Translating the combination of TGFβ blockade and radiotherapy into clinical development in glioblastoma
To improve multimodal glioblastoma treatment strategies, it appears useful to integrate a selective inhibitor of the TβR-I kinase, which may be able to potentiate radiation responses by increasing apoptosis and cancer-stem-like cell targeting while blocking DNA damage repair, invasion, mesenchymal t...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
17 Oct 2012
|
| In: |
OncoImmunology
Year: 2012, Volume: 1, Issue: 6, Pages: 943-945 |
| ISSN: | 2162-402X |
| DOI: | 10.4161/onci.19789 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.4161/onci.19789 Verlag, kostenfrei, Volltext: https://doi.org/10.4161/onci.19789 
|
| Author Notes: | Mengxian Zhang, Michael Lahn & Peter E. Huber |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1578074231 | ||
| 003 | DE-627 | ||
| 005 | 20220814203622.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180730s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4161/onci.19789 |2 doi | |
| 035 | |a (DE-627)1578074231 | ||
| 035 | |a (DE-576)508074231 | ||
| 035 | |a (DE-599)BSZ508074231 | ||
| 035 | |a (OCoLC)1341016093 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Zhang, Mengxian |e VerfasserIn |0 (DE-588)116358214X |0 (DE-627)1027905331 |0 (DE-576)508073685 |4 aut | |
| 245 | 1 | 0 | |a Translating the combination of TGFβ blockade and radiotherapy into clinical development in glioblastoma |c Mengxian Zhang, Michael Lahn & Peter E. Huber |
| 246 | 3 | 3 | |a Translating the combination of TGFbeta blockade and radiotherapy into clinical development in glioblastoma |
| 264 | 1 | |c 17 Oct 2012 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 17 Oct 2012 | ||
| 500 | |a Gesehen am 30.07.2018 | ||
| 520 | |a To improve multimodal glioblastoma treatment strategies, it appears useful to integrate a selective inhibitor of the TβR-I kinase, which may be able to potentiate radiation responses by increasing apoptosis and cancer-stem-like cell targeting while blocking DNA damage repair, invasion, mesenchymal transition and angiogenesis.1 | ||
| 650 | 4 | |a combination therapy | |
| 650 | 4 | |a glioblastoma | |
| 650 | 4 | |a radiotherapy | |
| 650 | 4 | |a stem cells | |
| 650 | 4 | |a TGFβ | |
| 700 | 1 | |a Lahn, Michael |e VerfasserIn |0 (DE-588)116361405X |0 (DE-627)1027927467 |0 (DE-576)508084687 |4 aut | |
| 700 | 1 | |a Huber, Peter E. |d 1965- |e VerfasserIn |0 (DE-588)1074678869 |0 (DE-627)832350109 |0 (DE-576)442767803 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoImmunology |d Abingdon : Taylor & Franics, 2012 |g 1(2012), 6, Seite 943-945 |h Online-Ressource |w (DE-627)683365428 |w (DE-600)2645309-5 |w (DE-576)356728366 |x 2162-402X |7 nnas |a Translating the combination of TGFβ blockade and radiotherapy into clinical development in glioblastoma |
| 773 | 1 | 8 | |g volume:1 |g year:2012 |g number:6 |g pages:943-945 |g extent:3 |a Translating the combination of TGFβ blockade and radiotherapy into clinical development in glioblastoma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4161/onci.19789 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.4161/onci.19789 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180730 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 1074678869 |a Huber, Peter E. |m 1074678869:Huber, Peter E. |d 50000 |e 50000PH1074678869 |k 0/50000/ |p 3 |y j | ||
| 998 | |g 116358214X |a Zhang, Mengxian |m 116358214X:Zhang, Mengxian |d 910000 |d 911400 |e 910000PZ116358214X |e 911400PZ116358214X |k 0/910000/ |k 1/910000/911400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1578074231 |e 3019754208 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"language":["eng"],"pubHistory":["1.2012 -"],"titleAlt":[{"title":"Onco Immunology"}],"note":["Gesehen am 13.12.2022"],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"eki":["683365428"],"zdb":["2645309-5"],"issn":["2162-402X"]},"recId":"683365428","origin":[{"dateIssuedDisp":"2012-","dateIssuedKey":"2012","publisherPlace":"Abingdon ; Austin, Tex.","publisher":"Taylor & Franics ; Landes Bioscience"}],"disp":"Translating the combination of TGFβ blockade and radiotherapy into clinical development in glioblastomaOncoImmunology","title":[{"title":"OncoImmunology","title_sort":"OncoImmunology"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"pages":"943-945","year":"2012","issue":"6","extent":"3","text":"1(2012), 6, Seite 943-945","volume":"1"}}],"title":[{"title":"Translating the combination of TGFβ blockade and radiotherapy into clinical development in glioblastoma","title_sort":"Translating the combination of TGFβ blockade and radiotherapy into clinical development in glioblastoma"}],"physDesc":[{"extent":"3 S."}],"language":["eng"],"titleAlt":[{"title":"Translating the combination of TGFbeta blockade and radiotherapy into clinical development in glioblastoma"}],"note":["Published online: 17 Oct 2012","Gesehen am 30.07.2018"],"person":[{"role":"aut","family":"Zhang","display":"Zhang, Mengxian","given":"Mengxian"},{"given":"Michael","role":"aut","family":"Lahn","display":"Lahn, Michael"},{"given":"Peter E.","display":"Huber, Peter E.","family":"Huber","role":"aut"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1578074231","id":{"doi":["10.4161/onci.19789"],"eki":["1578074231"]},"name":{"displayForm":["Mengxian Zhang, Michael Lahn & Peter E. Huber"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"17 Oct 2012"}]} | ||
| SRT | |a ZHANGMENGXTRANSLATIN1720 | ||